Venture_Socks_RZ_RGB_300dpi(2)_edited.pn
icon-prizes.png

WINNERS

orange arrows.png

PiKe Pharma GmbH

2008

Health & Nutrition

2000_W1_Carbofix.png
Sensirion_edited.jpg

PiKe Pharma GmbH develops small-molecule drugs for infectious diseases employing fragment-based synthesis of unique chemical libraries in combination with an innovative screening technology for the identification of novel protein-protein interaction inhibitors. The company was liquidated in 2015.